Perspectives for gene therapy in renal diseases

Area of Science:

• Nephrology
• Gene Therapy
• Biotechnology

Background:

• Somatic cell gene therapy has advanced significantly, with successful clinical trials.
• Understanding renal disease pathophysiology and gene transfer techniques are key drivers for novel therapies.
• Gene therapy offers potential for incurable renal diseases, including Alport syndrome and polycystic kidney disease.

Purpose of the Study:

• To review the progress and potential of gene therapy in nephrology.
• To highlight applications in renal cancer, anemia, glomerulonephritis, and renal fibrosis.
• To discuss emerging techniques and future prospects in renal gene therapy.

Main Methods:

• Review of recent advancements in somatic cell gene therapy for renal diseases.
• Analysis of gene therapy applications in experimental models and clinical trials.
• Exploration of novel techniques like stem cell technology and mRNA silencing.

Main Results:

• Gene therapy shows promise for renal cancer, anemia in uremic rats, glomerulonephritis, and renal fibrosis.
• Inducible erythropoietin gene therapy demonstrates potential for anemia treatment.
• Transplant kidney gene modification for tolerance induction is an active area of research.

Conclusions:

• Gene therapy holds significant potential for treating a range of renal diseases.
• Emerging technologies like stem cells and mRNA silencing are expanding therapeutic options.
• Continued research in gene therapy promises exciting future clinical applications in nephrology.